Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Clin Cancer Res. 2016 Sep 28;23(7):1852–1861. doi: 10.1158/1078-0432.CCR-16-0610

Figure 4. Potential Clinical Implications.

Figure 4

Assessing SMN susceptibility may be integrated into the work up for an initial cancer diagnosis. Germline sequencing in patients may differentiate individuals with elevated risk. These individuals might be offered adjusted therapies and more focused surveillance.